(0.17%) 5 317.10 points
(0.21%) 39 990 points
(0.13%) 16 765 points
(0.60%) $79.10
(2.81%) $2.48
(-0.32%) $2 387.20
(0.71%) $29.94
(-0.34%) $1 066.50
(0.13%) $0.920
(0.30%) $10.70
(0.08%) $0.789
(0.25%) $90.91
Live Chart Being Loaded With Signals
Carmell Therapeutics Corporation focuses on the development of plasma-based bioactive material (PBM) to stimulate tissue repair or growth after injury, disease, and aging...
Stats | |
---|---|
Today's Volume | 14 252.00 |
Average Volume | 7 473.00 |
Market Cap | 48.30M |
EPS | $0 ( 2024-03-12 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -1.520 |
ATR14 | $0.0810 (3.48%) |
Carmell Therapeutics Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Carmell Therapeutics Financials
Annual | 2023 |
Revenue: | $0 |
Gross Profit: | $-124 788 (0.00 %) |
EPS: | $-1.400 |
FY | 2023 |
Revenue: | $0 |
Gross Profit: | $-124 788 (0.00 %) |
EPS: | $-1.400 |
FY | 2022 |
Revenue: | $0 |
Gross Profit: | $-242 556 (0.00 %) |
EPS: | $-0.460 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Carmell Therapeutics
Carmell Therapeutics Corporation focuses on the development of plasma-based bioactive material (PBM) to stimulate tissue repair or growth after injury, disease, and aging. Its lead product candidate is CT-101 bone healing accelerant for tibia fracture healing, foot/ankle fusion, spinal fusion, dental bone graft substitute, and bone void filler; and tissue healing accelerant for androgenetic alopecia and chronic wound healing. The company was founded in 2008 and is based in Pittsburgh, Pennsylvania.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators